NCT04266301 2026-01-13
STIMULUS-MDS2
Novartis
Phase 3 Terminated
Clinical Trials
4 trialsNCT06647862 2025-11-25
IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 3 Recruiting
NCT03268954 2025-10-29
PANTHER
Takeda
Phase 3 Completed
NCT04842604 2023-12-18
Continuation Study of B1371019(NCT03416179) and B1371012(NCT02367456) Evaluating Azacitidine With Or Without Glasdegib In Patients With Previously Untreated AML, MDS or CMML
Pfizer
Phase 3 Completed